Kostas Odysseas D
Insider CIK 1483080 · INVA Director · AMRN Director · ARMP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2026-04-18 | 2026-04-21 | 838 | — | $0 | 838 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2026-04-18 | 2026-04-21 | 838 | — | $0 | 1,239 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | F Tax w/h | 2026-04-18 | 2026-04-21 | 403 | $14.98 | $6.0K | 836 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2026-03-09 | 2026-03-11 | 25,640 | — | $0 | 25,640 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2025-04-18 | 2025-04-22 | 838 | — | $0 | 1,676 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | F Tax w/h | 2025-04-18 | 2025-04-22 | 437 | $9.11 | $4.0K | 401 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2025-04-18 | 2025-04-22 | 838 | — | $0 | 838 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2025-02-05 | 2025-02-07 | 54,343 | — | $0 | 54,343 | SEC↗ |
| INVA Innoviva, Inc. | A Award deriv | 2024-06-17 | 2024-06-20 | 10,000 | — | $0 | 30,000 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2024-06-17 | 2024-06-20 | 13,923 | — | $0 | 122,625 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2024-04-18 | 2024-04-19 | 50,287 | — | $0 | 50,287 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2024-04-18 | 2024-04-19 | 179,795 | — | $0 | 179,795 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2024-03-14 | 2024-03-18 | 39,666 | — | $0 | 39,666 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2024-03-14 | 2024-03-18 | 54,343 | — | $0 | 94,009 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2023-12-21 | 2023-12-26 | 10,461 | — | $0 | 10,461 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2023-07-21 | 2023-07-21 | 258,598 | — | $0 | 284,598 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2023-07-21 | 2023-07-21 | 180,804 | — | $0 | 180,804 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2023-07-21 | 2023-07-21 | 94,866 | — | $0 | 94,866 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2023-07-21 | 2023-07-21 | 60,268 | — | $0 | 60,268 | SEC↗ |
| INVA Innoviva, Inc. | A Award deriv | 2023-05-22 | 2023-05-24 | 10,000 | — | $0 | 20,000 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2023-05-22 | 2023-05-24 | 16,495 | — | $0 | 108,702 | SEC↗ |
| INVA Innoviva, Inc. | A Award deriv | 2022-04-25 | 2022-04-27 | 10,000 | $10000.00 | $100.00M | 0 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2022-04-25 | 2022-04-27 | 12,647 | — | $0 | 92,207 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2022-04-13 | 2022-04-15 | 33,000 | — | $0 | 33,000 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2021-06-07 | 2021-06-09 | 28,000 | — | $0 | 28,000 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2021-05-14 | 2021-05-20 | 17,482 | — | $0 | 79,560 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2020-12-08 | 2020-12-09 | 23,000 | — | $0 | 23,000 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2020-04-24 | 2020-04-28 | 16,917 | — | $0 | 62,078 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2020-02-12 | 2020-02-14 | 27,383 | — | $0 | 27,383 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2019-04-24 | 2019-05-24 | 16,399 | — | $0 | 45,161 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2018-04-24 | 2018-04-26 | 14,249 | — | $0 | 28,762 | SEC↗ |
| INVA Innoviva, Inc. | A Award | 2017-12-19 | 2017-12-21 | 14,513 | — | $0 | 14,513 | SEC↗ |